Corin Group PLC Directorate Changes (2158U)
24 Décembre 2012 - 8:01AM
UK Regulatory
TIDMCRG
RNS Number : 2158U
Corin Group PLC
24 December 2012
FOR IMMEDIATE RELEASE
24 December 2012
CORIN GROUP PLC
DIRECTORATE CHANGES
Following the declaration that the offer for Corin Group PLC
(LSE: CRG, "Corin" or the "Group") has been declared wholly
unconditional, Corin today announces that Peter Huntley, Linda
Wilding and David Young have resigned and that Stefano Alfonsi has
been appointed as Chief Executive Officer and acting Chairman with
immediate effect.
Stefano Alfonsi has many years' experience at senior management
level in the healthcare sector, including at Johnson and Johnson,
DePuy and Covidien and most recently as Chief Executive Officer of
Lima Corporate.
Stefano Alfonsi is currently employed by the medical devices
company Inion OY. Stefano will work for Corin following a short
transitional period.
In addition, Marco Fumagalli, Enrico Amo and Pierluca Antolini,
all of whom are director of 2IL Orthopaedics Limited, have all been
appointed to the Board of Corin as non-executive directors.
Enrico Amo is a non-executive director of DiaSorin S.p.A, a
company incorporated under the laws of Italy and listed on the
Milan Stock Exchange.
There is no other information to be disclosed under Paragraph
9.6.13 of the Listing Rules.
Enquiries
Corin Group PLC 01285 659 866
Stefano Alfonsi
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOALLFFTFLLLFIF
Corin (LSE:CRG)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Corin (LSE:CRG)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Corin Grp (London Stock Exchange): 0 recent articles
Plus d'articles sur Corin